epocrates: Drug Info & Pill ID vs Oncology Board Exam Review
A data-backed head-to-head — estimated revenue, downloads, ratings and pricing side by side, from live App Store signals. Updated continuously.
Revenue / mo
$310k–$1.3M
$200–$900
Downloads / mo
280k–1.2M
60–300
Rating
★ 4.46 (7k)
★ 4.59 (129)
Pricing
Free + IAP
Free + IAP
Category
Medical
Medical
Released
7.3y ago
9.1y ago
Verdict: epocrates: Drug Info & Pill ID earns more — an estimated $310k–$1.3M/mo, versus $200–$900/mo for Oncology Board Exam Review.